ResMed Inc. (RME.F)
| Previous close | 197.90 |
| Open | 199.35 |
| Bid | 198.20 x 20000 |
| Ask | 199.70 x 20000 |
| Day's range | 198.30 - 202.00 |
| 52-week range | 126.40 - 218.20 |
| Volume | |
| Avg. volume | 25 |
| Market cap | 29.139B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 32.89 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.79 (0.90%) |
| Ex-dividend date | 08 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
ResMed Announces Participation in the RBCCM Global Healthcare Conference
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez, Chief Medical Officer, and Amy Wakeham, Chief Investor Relations Officer, will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, beginning at approximately 4:05 p.m. (Eastern Daylight Time) at the InterContinental New York Barclay, in New York, NY. More information about this event, including access to the live, audio-only webcast, may b
- GlobeNewswire
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2024. Third Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 7% to $1.2 billion; up
- GlobeNewswire
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:http://investor.resmed.com • Da
